Please provide your email address to receive an email when new articles are posted on . An AI model correctly identified 22 of 31 adults as having acromegaly strictly based on voice recordings. The ...
The journal Pituitary has highlighted research led by Manel Puig, head of the Endocrine, Thyroid and Obesity Research Group at the Germans Trias i Pujol Research Institute (IGTP), which explores the ...
Researchers from Alteogen Inc. and affiliated organizations presented preclinical characterization of a novel long-acting growth hormone receptor (GHR) antagonist, ALT-B5, optimized for efficacy and ...
The Gwangju Institute of Science and Technology (GIST) announced on the 30th that a team co-led by Professor Oh Chang-myung of the Department of Biomedical Science and Engineering and Professor Yoon ...
Acromegaly is a rare but serious hormonal disorder caused by excess growth hormone, usually due to a benign tumour in the pituitary gland. It typically develops in adulthood and leads to noticeable ...
Please provide your email address to receive an email when new articles are posted on . Higher on-treatment serum insulin-like growth factor I levels may be associated with higher all-cause mortality ...
While the most obvious signs of acromegaly are changes to your facial features and unusual growth in your hands and feet, it also has effects no one else can see. This rare disease is caused by an ...
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results